Skip to main content
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.100
+0.029 (0.94%)
Jun 5, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cell-based Therapeutics
2.54M
Log In
Log In
Log In
Log In
Upgrade
Cell-based Therapeutics Growth
48.80%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
2.54M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
48.80%
Log In
Log In
Log In
Log In
Upgrade